SCHEMBL16410696

SCHEMBL16410696

CCC1(CC)C(N=NCc2cccc(C=N)c2)=Nc2cc(CN=[N+]=[N-])c(CN=[N+]=[N-])cc2N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410684 0.68 — —
SCHEMBL16410695 0.67 — —
SCHEMBL16410849 0.66 — —
SCHEMBL16410744 0.57 ACAT2 (0.31) —
SCHEMBL14530040 0.55 TP53 (0.42) —
SCHEMBL13887515 0.55 GRIN2D (0.43) —
SCHEMBL14872978 0.55 PDE2A (0.39) —
SCHEMBL19523655 0.53 CYP19A1 (0.45) —
SCHEMBL26610945 0.53 PNMT (0.48) —
SCHEMBL14570167 0.52 TP53 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback